More on Onyx (ONXX): Adam Feurstein at TheStreet.com is speculating that Kyprolis, the company's...


More on Onyx (ONXX): Adam Feurstein at TheStreet.com is speculating that Kyprolis, the company's multiple myeloma drug, has been approved. The FDA's Oncologic Drugs Advisory Committee is reviewing the drug at its meeting today. Ligand Pharmaceuticals (LGND +0.8%) is spiking higher on the news.

Comments (1)
  • Orangeman44
    , contributor
    Comments (17) | Send Message
     
    I see LGND down over 2%
    20 Jul 2012, 01:57 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs